Log In
Print this Print this

Prenetics V test

  Manage Alerts
Collapse Summary General Information
Company Prenetics Inc.
DescriptionDNA based non-invasive prenatal test that detects for a total of 16 fetal chromosomal aneuploidies using a single maternal blood draw to screen for T21, T18 and T1
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationGenetic disorders, Diagnostic
Indication DetailsDetect fetal health problems including Down Syndrome, Edwards Syndrome and Patau Syndrome
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today